• Gilead Sciences top products by revenue 2011-2016 | Statistic

Health & Pharmaceuticals›
Pharmaceutical Products & Market›
Gilead Sciences' top products based on revenue 2011-2016

Premium

Top products of Gilead Sciences from 2011 to 2016, based on revenue (in million U.S. dollars)

Loading statistic...

© Statista 2017

Show further information

Show sources information

About This Statistic

This statistic shows the top products of biopharmaceutical company Gilead Sciences from 2011 to 2016, based on revenue. Gilead Sciences Inc. is headquartered in California and is specialized in discovering, developing and commercializing therapeutics. In 2011, Gilead Sciences' top product Atripla generated some 3.2 billion U.S. dollars in revenue.

Special Functions

Download as ...

Options

Percentage of genetically modified crops in the U.S. by type 2016

Percentage of genetically modified crops in the U.S. by type 2016

Gross profit margin of select U.S. biotech and drugs companies Q4 2016

Gross profit margin of select U.S. biotech and drugs companies Q4 2016

Top global biotech companies based on market capitalization 2016

Top global biotech companies based on market capitalization 2016

Number of biotech companies in the U.S. 2012-2016

Number of biotech companies in the U.S. 2012-2016

Top-selling biotech drugs based on revenue 2015

Top-selling biotech drugs based on revenue 2015

Monsanto's seed and genomics segment net sales 2011-2016

Monsanto's seed and genomics segment net sales 2011-2016

Statista Accounts: Access All Statistics. Starting from $588 / Year

Prices & Access

Statistics on "Biotech industry"

Overview U.S. and Europe

The most important statistics

Key figures on established biotechnology centers worldwide from 2012 to 2016* Key figures on established biotech centers worldwide 2012-2016
Key figures on U.S. public biotech companies from 2012 to 2016Key figures on U.S. public biotech companies 2012-2016
Number of biotechnology companies in the United States from 2012 to 2016Number of biotech companies in the U.S. 2012-2016
Financing data of U.S. biotech companies from 2012 to 2016United States biotech financing data 2012-2016
Commercial leaders vs. other companies in U.S. biotechnology in 2016Commercial leaders vs. other companies in U.S. biotech 2016
Value of the NASDAQ biotech Index from 2010 to 2015 NASDAQ biotech index closing values 2010-2015
Key figures on European public biotech companies from 2012 to 2016European public biotech companies - key figures 2012-2016
Total capital raised in biotechnology industry in the U.S. and Europe from 2000 to 2016 (in million U.S. dollars)*Total raised capital in U.S. and Europe biotechnology industry 2000-2016

Global companies

The most important statistics

Revenue of top global biotechnology companies in 2015 (in million U.S. dollars)Top global biotech companies - revenue 2015
Top global biotechnology companies based on R&D expenditure in 2014 (in million U.S. dollars)Top global biotech companies based on R&D expenditure 2014
Selected top biotechnology companies based on number of employees worldwide in 2015Top global biotech companies based on number of employees 2015
Top global biotechnology companies based on market capitalization as of 2016 (in billion U.S. dollars)Top global biotech companies based on market capitalization 2016
Selected biotechnology mergers and acquisitions in the U.S. and Europe by total potential value in 2016 (in million U.S. dollars)Select M&As in U.S. and Europe biotechnology industry 2016
Biotech alliances with big up-front payments in the U.S. and Europe in 2016 (in million U.S. dollars)Alliances in U.S. and Europe biotechnology industry with big up-front payments 2016

U.S. companies

The most important statistics

Gilead Sciences' revenue and net income from 2006 to 2016 (in million U.S. dollars)Gilead Sciences' revenue and net income 2006-2016
Top products of Gilead Sciences from 2011 to 2016, based on revenue (in million U.S. dollars)Gilead Sciences' top products based on revenue 2011-2016
Total revenue of biotech company Amgen from 2004 to 2016 (in million U.S. dollars)Amgen's total revenue 2004-2016
Revenues of selected Amgen's top products from 2006 to 2016 (in million U.S. dollars)Amgen's top product revenues 2006-2016
Biogen's revenue and net income from 2007 to 2016 (in million U.S. dollars)Biogen's revenue and net income 2007-2016
Biogen's top products from 2014 to 2016, based on revenue (in million U.S. dollars)Biogen's top products based on revenue 2014-2016
Market capitalization compound annual growth rate of selected U.S. biotech companies between 2012 and 2016Market cap CAGR of biotech companies in the U.S. 2012-2016
Pre-commercial U.S. biotech companies with large market capitalization as of March 2017 (in million U.S. dollars)*Pre-commercial biotech companies with large market caps in the U.S. 2017

Top U.S. regions

The most important statistics

Number of public biotech companies in the U.S. from 2012 to 2014, by geographic areaNumber of public biotech companies in the U.S. 2012-2014 by region
U.S. biotech industry revenues from 2012 to 2014, by geographic area (in million U.S. dollars)*U.S. biotech industry revenues by region 2012-2014
Market capitalization of U.S. public biotech companies from 2012 to 2014, by geographic area (in million U.S. dollars)Market capitalization of U.S. biotech companies by region 2012-2014
U.S. biotech industry research and development expenses from 2012 to 2014, by geographic area (in million U.S. dollars)*U.S. biotech industry research and development expenses by region 2012-2014

Products/R&D

The most important statistics

Total global biologics spending from 2002 and 2017 (in billion U.S. dollars)Global biologics spending 2002-2017
Top 10 best-selling biotech drugs worldwide in 2015 (in billion U.S. dollars)Top-selling biotech drugs based on revenue 2015
Number of biologic medicines in development as of June 2017, by therapeutic category*Pharmaceuticals: biologic medicines in development 2017 by category
U.S. biopharmaceutical goods export volume from 2002 to 2016 (in billion U.S. dollars)U.S. biopharmaceutical export volume 2002-2016
Top biotech and pharma product launches in 2017 and revenue forecast for 2022 (in million U.S. dollars)Projection of top 2017 pharma and biotech launches by revenue 2022
Total U.S. pharmaceutical and biotech revenues for products 5 years after launch from 2007 to 2016 (in billion U.S. dollars)Total U.S. pharma and biotech product sales 5 years after launch 2007-2016

Biotech in agriculture

The most important statistics

Acreage of genetically modified crops worldwide from 2003 to 2016 (in million hectares)Acreage of genetically modified crops worldwide 2003-2016
Acreage of genetically modified crops worldwide from 2004 to 2016, by leading country (in million hectares)*Acreage of genetically modified crops 2004-2016, by country
Percentage of genetically modified crops in the U.S. in 1997 and 2016, by type (as percent of total acreage)Percentage of genetically modified crops in the U.S. by type 2016
Monsanto's net sales in the seeds and genomics segment from 2011 to 2016, by specialty (in million U.S. dollars)*Monsanto's seed and genomics segment net sales 2011-2016
Sales of Syngenta AG worldwide from 2013 to 2016, by segment (in billion U.S. dollars)Syngenta AG's sales worldwide by segment 2013-2016
Bayer CropScience's revenue from 2005 to 2016 (in million euros)Bayer CropScience's revenue 2005-2016

Related Studies: Available to Download in PDF or PPTX Format

Biotech industry

All Information
in one Presentation

Biotech industry

92 page/s
English
pptx
Detailed references

Everything On "Biotech industry" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Statista for Your Company: The Research and Analysis Tool

Product Film
Statistics
Downloads

Our Premium Statistics - facts for your business

Currently, Statista provides more than 1 million statistics. 93 percent (all Premium content) are exclusively accessible via our professional accounts.

Unlimited access

As a Statista Premium customer, you receive unlimited access to all statistics at all times. Including downloads of data in the most common formats (XLS, PDF & PNG). Create relevant and significant statistics in no time.

You are in good company

Google

Samsung

Unilever

Procter and Gamble

Adobe

Telekom

PayPal

Otto

Further Content: Statistics, Studies, and Topic Pages

Statistics

Topics

Studies

Popular Related Keywords

Our Business Solutions: Save Time and Money

only

$588^*

per year

Your advantages

Full access to all our statistics
Download as XLS, PDF & PNG
Relevant data: complete source information

All functions of our platform illustrated face-to-face

Learn how Statista supports your company
Extensive tour across the whole portal
Personal guidance by our support team

Request webinar

The knowledge database for your company

All functions of the Premium Account
Access to dossiers, forecasts and studies
Access to our international database
Publishing rights and other exclusive functions

* All products require an annual contract.
Prices do not include sales tax
(New York residents only).